-Bridge the Gap Bring the Change

Tag Patent

Don’t let Nestlé turn a traditional cure into a corporate cash cow #mustshare

  Nigella sativa — more commonly known as fennel flower — has been used as a cure-all remedy for over a thousand years. It treats everything from vomiting to fevers to skin diseases, and has been widely available in impoverished… Continue Reading →

#India is committing selective genocide in healthcare #mustread

FOR THE RECORD The recent release of the documentary Fire in the Blood has revived the debate on whether patents block access to life-saving medicines. Dr Yusuf K Hamied, chairperson of Cipla and the ‘star’ of the film, made international… Continue Reading →

#India – Film on “Novartis and the Battle to Access Essential Drugs” #healthcare #mustshare

    This feature examines why India‘s patenting regime, despite being pro-public in terms of promoting easier access to drugs, has faced considerable criticism, particularly post the Supreme Court decision in the Novartis case. The feature examines why India has… Continue Reading →

After India, Australia too eyes tighter drug patent standards #Novartis judgement Impact

Rema Nagarajan, TNN | Apr 11, 2013, 05.31 AM IST NEW DELHI: India is not alone in raising the bar for granting patents on pharmaceutical products. Australia, having reviewed pharma patents, has questioned the benefit of allowing patent extension beyond 20 years… Continue Reading →

Novartis case: Supreme Court’s historic decision on Section 3(d) #TRIPS #Patent

Anand Grover | Apr 2, 2013, After 2005 India started granting product patents on medicines. However, Section S ection 3(d), one of the safeguards introduced by Parliament, seeks to prevent patenting of new forms of known substances unless they exhibit enhanced efficacy…. Continue Reading →

#India- SC rejects Novartis’s patent plea for cancer drug Glivec #goodnews

Vidya Krishnan , livemint Court says Glivec does not meet any standard of ‘novelty or inventiveness’ to qualify for a patent First Published: Mon, Apr 01 2013. Shares of Novartis India fell as much as 7% after the Supreme Court judgement. The… Continue Reading →

Press Release- Campaign for Affordable Trastuzumab

The Department of Pharmaceuticals, Ministry of Commerce has just released a report by a committee set up to examine the issue of price negotiations for patented drugs.  Comments are being invited from stakeholders.   The Campaign for Access to Affordable… Continue Reading →

Supreme Court Canada invalidates Pfizer’s Viagra Patent

Supreme Court Voids Viagra Patent as Insufficient Disclosure Means It Fails the “Patent Bargain” Canada’s top court has ruled that Pfizer’s patent on their groundbreaking erectile dysfunction drug Viagra won’t be valid for much longer. The unanimous decision opens the… Continue Reading →

Immediate Release- Patients succeed in overturning first ever product patent on medicine in India #goodnews

Hope for hep-C patients: Context and Background  Today, the Bench of Intellectual Property Appellate Board, comprising Justice Prabha Sridevan (Chairperson) and Mr DPS Parmar (Technical Member), set aside the first ever product patent on a medicine granted in India to… Continue Reading →

© 2024 Kractivism — Powered by WordPress

Theme by Anders NorenUp ↑